MDxHealth Announces Results of its Extraordinary General Shareholders’ Meeting
June 30 2023 - 4:00PM
MDxHealth Announces Results of its Extraordinary General
Shareholders’ Meeting
NEWS RELEASE - REGULATED
INFORMATION 30
June 2023, 10:00 p.m.
CEST
MDxHealth Announces
Results of its
Extraordinary General Shareholders’
Meeting
IRVINE, CA, and
HERSTAL, BELGIUM – 30 June 2023 –
MDxHealth SA (Nasdaq and Euronext Brussels: MDXH)
("mdxhealth" or the
"Company"), a commercial-stage precision
diagnostics company, today held an extraordinary general
shareholders' meeting ("EGM").
The items on the agenda of the EGM included the
issuance of a new share option plan called the "2023 Share Option
Plan" and the renewal of the authorization to the board of
directors to increase the share capital within the framework of the
authorized capital. There was no attendance quorum for the EGM, and
the proposed resolutions that were submitted to the meeting were
all duly passed.
The minutes of the EGM and documents that were
submitted to the meeting can be accessed via the Company’s
website.
About
mdxhealth®
Mdxhealth is a commercial-stage precision
diagnostics company that provides actionable molecular information
to personalize patient diagnosis and treatment. The Company’s tests
are based on proprietary genomic, epigenetic (methylation) and
other molecular technologies and assist physicians with the
diagnosis and prognosis of urologic cancers and other urologic
diseases. The Company’s U.S. headquarters and laboratory operations
are in Irvine, California, with additional laboratory operations in
Plano, Texas. European headquarters are in Herstal, Belgium, with
laboratory operations in Nijmegen, The Netherlands. For more
information, visit mdxhealth.com and follow us on social media at:
twitter.com/mdxhealth, facebook.com/mdxhealth and
linkedin.com/company/mdxhealth.
For more
information:mdxhealth
info@mdxhealth.com
LifeSci Advisors (IR &
PR)
US: +1 949 271 9223
ir@mdxhealth.com
NOTE: The
mdxhealth logo, mdxhealth, Confirm mdx, Select mdx,
Resolve mdx, Genomic Prostate Score, GPS and Monitor mdx are
trademarks or registered trademarks of MDxHealth SA. All other
trademarks and service marks are the property of their respective
owners.
Mdxhealth (LSE:0O8G)
Historical Stock Chart
From Apr 2024 to May 2024
Mdxhealth (LSE:0O8G)
Historical Stock Chart
From May 2023 to May 2024